|
(Health-NewsWire.Net, October 16, 2019 ) Market Overview:
A therapeutic vaccine are the biological preparations applied post infection confirmation, in order to induce antiviral immunity to alter the course of the disease. Therapeutic vaccine has expanded the horizon of chronic disease treatment. However, fast-track approvals by US FDA for therapeutic vaccine for various disease shall be essentially intensified. Due to increasing chronic infectious diseases, allergic conditions, auto immune disorders, cancer etc., and lack of vaccines approvals, is expected to create the negative shift towards the healthcare expenditure for low to emerging economic county population.
Market Dynamics:
Therapeutic Vaccines Market is driven by rising incidences of chronic infectious diseases, cancer, Alzheimer’s disease etc.
However huge capital expenditure in vaccine development is hampering the market growth. Merely 22% of the initiatives were forecasted in 1996 to successfully reach the market after 10 years of development.
Market Segmentation:
Based on type, the Therapeutic Vaccines Market is segmented into Tumor cell vaccine, Antigen vaccines, Dendritic Cell vaccine, DNA vaccine.
Rising incidences of cancer leading to rising demand for the development of tumor cell vaccines is one of the dominating factors, propelling the global therapeutic vaccines market.
On the basis of disease type, the therapeutic vaccines market is segmented into Autoimmune Disease Vaccine, Infectious Disease Vaccine, Neurological Disease Vaccines, Addiction Vaccine, and others.
On the basis of technology, the therapeutic vaccines market is segmented into Autologous Vaccines and Allogeneic Vaccines. Autologous vaccines are expected to boost the market over the period of forecast.
Geographical Analysis:
Geographically, the market is divided into North America, Europe, South America, Asia-Pacific, and the Middle East and Africa.
North America is dominating the Therapeutic Vaccines Market in 2018 and estimated to hold largest market size over the forecast period (2019-2026) owing to rising incidence of chronic infectious diseases, cancer, Alzheimer’s, and others.
Competitive Analysis:
Some of the major players in the Therapeutic Vaccines Market are GlaxoSmithKline, Merck & Co., Pfizer, Vaccinogen Inc. Sanofi Agenus Inc.
GlaxoSmithKline has an extensive portfolio and a pipeline of therapeutic vaccines. GSK1265744 (cabotegravir) for HIV (pre-exposure prophylaxis) is in Phase III which acts as a HIV integrase inhibitor. GSK137173A (Shingrix) for Herpes Zoster prophylaxis is a immune compromised vaccine in Phase III.
View full report: https://www.datamintelligence.com/research-report/therapeutic-vaccine-market
Download free sample: https://www.datamintelligence.com/download-sample/therapeutic-vaccine-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: pr@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
|
